Transparency Matters is a call to action launched by Medical Publishing Insights & Practices (MPIP), designed to raise awareness, provide resources, and improve the quality and transparency in reporting the results of industry-sponsored research. Similar to ISMPP, Transparency Matters seeks to broaden the conversation around transparency in medical publications, promote best practices, and engage interested parties in this important mission.
“With Transparency Matters, MPIP aims to focus the conversation on transparency in medical publications; encourage advocacy, individual accountability, and broad collaboration among interested parties; and provide the tools to promote best practices,” said Bernadette Mansi, Chair of MPIP, and Director, Publications & Disclosure Practices, GlaxoSmithKline.
ISMPP encourages its members and all those who are involved in reporting the results of industry-sponsored research to take the Transparency Pledge! More information is available in the Transparency Matters section of the MPIP website (www.mpip-initiative.org), which serves as a resource for published MPIP research, tools, and recommendations.
As background, MPIP was founded by members of the pharmaceutical industry and ISMPP to elevate trust, transparency, and integrity in reporting the results of industry-sponsored research. The major goal of MPIP is to encourage more effective partnerships between trial sponsors and medical journals to continue to raise standards in medical publications and expand access to research results.
I pledge to support the timely, accurate, complete, balanced, and transparent reporting of industry-sponsored research results in adherence with appropriate guidelines and ethical standards: 1) to ensure practitioners have access to full information when making treatment decisions for their patients; and 2) to foster a culture of mutual respect, understanding, and trust among authors, the pharmaceutical industry, and medical journals/editors to facilitate this process.